Raymond James & Associates’s Xometry XMTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$5.29M Buy
287,986
+1,586
+0.6% +$26K ﹤0.01% 1620
2024
Q2
$3.31M Sell
286,400
-899
-0.3% -$14.1K ﹤0.01% 1861
2024
Q1
$4.85M Buy
287,299
+11,276
+4% +$306K ﹤0.01% 1602
2023
Q4
$9.91M Sell
276,023
-4,107
-1% -$88.1K 0.01% 1115
2023
Q3
$4.76M Sell
280,130
-671
-0.2% -$12.7K ﹤0.01% 1483
2023
Q2
$5.95M Sell
280,801
-150
-0.1% -$2.62K ﹤0.01% 1367
2023
Q1
$4.21M Sell
280,951
-63,631
-18% -$1.67M ﹤0.01% 1581
2022
Q4
$11.1M Buy
344,582
+20,047
+6% +$936K 0.01% 942
2022
Q3
$18.4M Buy
324,535
+218
+0.1% +$10.2K 0.02% 640
2022
Q2
$11M Buy
324,317
+1,361
+0.4% +$46.9K 0.01% 930
2022
Q1
$11.9M Buy
322,956
+10,723
+3% +$490K 0.01% 977
2021
Q4
$16M Buy
+312,233
New +$16.1M 0.01% 860

Other funds holding XMTR

Raymond James & Associates's XMTR Position: Q3 2024 in Review

Raymond James & Associates increased its Xometry (XMTR) stake by 0.55% in Q3 2024, buying an estimated $26K and bringing the position to 287,986 shares worth $5.29M. The position accounts for ﹤0.01% of the portfolio, ranked #1620.

Raymond James & Associates first reported a position in XMTR in Q4 2021 and has held it in 12 quarters since. The position peaked at $18.4M in Q3 2022. 127 funds tracked by Wall St. Rank hold XMTR as of Q3 2024.

  • Raymond James & Associates held 287,986 shares of Xometry worth $5.29M as of Q3 2024.
  • Raymond James & Associates bought 1,586 Xometry shares in Q3 2024, an estimated $26K.
  • Xometry made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #1620 holding.
  • Raymond James & Associates first reported a position in Xometry in Q4 2021 and has held it in 12 quarters since.
  • Raymond James & Associates's Xometry position peaked at $18.4M in Q3 2022.
  • 127 funds tracked by Wall St. Rank held Xometry as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.